In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme

Published:2018-04-11 Issue:7 Volume:73 Page:1872-1879
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Karlowsky James A¹,Lob Sibylle H²,Kazmierczak Krystyna M²,Hawser Stephen P³,Magnet Sophie³,Young Katherine⁴,Motyl Mary R⁴,Sahm Daniel F²

Affiliation:

1. Department of Medical Microbiology and Infectious Diseases, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

2. International Health Management Associates, Inc., Schaumburg, IL, USA

3. IHMA Europe Sàrl, Monthey/VS, Switzerland

4. Merck & Co., Inc., Kenilworth, NJ, USA

Funder

Merck & Co., Inc.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/7/1872/25034386/dky107.pdf

Reference29 articles.

1. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE;Rice;J Infect Dis,2008

2. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens;Pogue;Clin Microbiol Infect,2015

3. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant Gram-negative bacteria;Mauldin;Antimicrob Agents Chemother,2010

4. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients;Bodro;Transplantation,2013

5. Progress and challenges in implementing the research on ESKAPE pathogens;Rice;Infect Control Hosp Epidemiol,2010

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli;Frontiers in Cellular and Infection Microbiology;2024-04-04

2. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-02

3. Global Resistance of Imipenem/Relebactam against Gram-Negative Bacilli: Systematic Review and Meta-Analysis;Current Therapeutic Research;2024

4. bla _KPC-2 overexpression and bla _GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China;Antimicrobial Agents and Chemotherapy;2023-11-15

5. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram‐Negative Bacterial Infections: A Phase 1b, Open‐Label, Single‐Dose Clinical Trial;The Journal of Clinical Pharmacology;2023-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3